The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease? is a research paper published in Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: 1R15NS107743
NINDS NIH HHS
Grant: R15 NS107743
National Institutes of Health
Grant: 1R15NS107743-01A1
Targeting the GABA-modulator microbiota against the progression of CNS inflammatory demyelination
Fields of Study
Keywords
Sustainable Development Goals